Free Article

Early risk assessment markers to delay cardiovascular disease

Guest Episode

The latest insights into cardiovascular disease and lipidology

Ep. #129 with Thomas Dayspring, M.D., FACP, FNLA

AMA

Real-world case studies—metabolic dysregulation, low testosterone, menopause, and more

Ep. #124 (AMA #15)

Guest Episode

Part V of V: Lp(a), inflammation, oxLDL, remnants, and more

Ep. #24 with Thomas Dayspring, M.D., FACP, FNLA

Guest Episode

Part IV of V: statins, ezetimibe, PCSK9 inhibitors, niacin, cholesterol and the brain

Ep. #23 with Thomas Dayspring, M.D., FACP, FNLA

Guest Episode

Part III of V: HDL, reverse cholesterol transport, CETP inhibitors, and apolipoproteins

Ep. #22 with Thomas Dayspring, M.D., FACP, FNLA

Guest Episode

Part II of V: Lipid metrics, lipid measurements, and cholesterol regulation

Ep. #21 with Thomas Dayspring, M.D., FACP, FNLA

Guest Episode

Part I of V: an introduction to lipidology

Ep. #20 with Thomas Dayspring, M.D., FACP, FNLA

Narrative glossary: lipids

Guest Episode

stress testing the lipid energy model

Ep. #19 with Dave Feldman

Transcript — The Drive — Dave Feldman

Free Article

Statins, Lp(a), and upcoming podcast guests

Podcast Episode

What every doctor, and the 10-20% of the population at risk, needs to know

Ep. #7

Guest Episode

A deep dive into heart disease

Ep. #3 with Ronald Krauss, M.D.

Free Article

Podcast, AMA, Lp(a), and Dr. Rosenrosen

Ep. #4

Free Article

Comedy plus time...

Free Article

MDMA and zero LDL-C

Free Article

A big predictor of heart disease risk that most doctors don't screen for

How did we come to believe saturated fat and cholesterol are bad for us?

The straight dope on cholesterol – Part IX

The straight dope on cholesterol – Part VIII

The straight dope on cholesterol – Part VII

The straight dope on cholesterol – Part VI

The straight dope on cholesterol – Part V